These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6547067)

  • 1. Cardioprotective actions of pentoxifylline in an animal model of acute myocardial ischaemia.
    Gallenkämper W; Rücker W; Schrör K
    Br J Pharmacol; 1984 Apr; 81(4):575-81. PubMed ID: 6547067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a single pentoxifylline administration on platelet sensitivity, plasma factor activity, plasma-6-oxo-PGF1 alpha and thromboxane B2 in healthy volunteers.
    Pohanka E; Sinzinger H
    Prostaglandins Leukot Med; 1986 May; 22(2):191-200. PubMed ID: 3523540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).
    Schrör K; Thiemermann C
    Br J Pharmacol; 1986 Apr; 87(4):631-7. PubMed ID: 3011166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of acute myocardial ischaemia with teopranitol--a novel organic nitrate.
    Thiemermann C; Smith EF; Schrör K
    Eur Heart J; 1986 May; 7(5):418-24. PubMed ID: 3732290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.
    Thiemermann C; Ney P; Schrör K
    Eur J Pharmacol; 1988 Oct; 155(1-2):57-67. PubMed ID: 2977337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
    Schrör K; Ohlendorf R; Darius H
    J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of ischemic myocardium by pinane thromboxane A2.
    Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
    Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of defibrotide in acute myocardial ischemia in the cat.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G
    Thromb Res; 1985 Apr; 38(1):71-81. PubMed ID: 3890260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of thromboxane inhibition on the severity of myocardial ischemia in cats.
    Smith EF; Lefer AM; Smith JB
    Can J Physiol Pharmacol; 1980 Mar; 58(3):294-300. PubMed ID: 7378931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
    Chyzy R; Lukjan H; Rość D; Bielawiec M; Sawicka J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):549-54. PubMed ID: 2446996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.
    Burke SE; Lefer AM; Smith GM; Smith JB
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6681711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin.
    Barton MH; Moore JN; Norton N
    Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses.
    Baskett A; Barton MH; Norton N; Anders B; Moore JN
    Am J Vet Res; 1997 Nov; 58(11):1291-9. PubMed ID: 9361895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage.
    Thiemermann C; Löbel P; Schrör K
    Am J Cardiol; 1985 Dec; 56(15):978-82. PubMed ID: 3907318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.
    Smith EF; Gallenkämper W; Beckmann R; Thomsen T; Mannesmann G; Schrör K
    Cardiovasc Res; 1984 Mar; 18(3):163-73. PubMed ID: 6200229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion.
    Coker SJ; Parratt JR
    Br J Pharmacol; 1984 Apr; 81(4):675-84. PubMed ID: 6547068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of defibrotide in acute lethal and nonlethal myocardial ischemia in the cat.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G; Berti F
    Haemostasis; 1986; 16 Suppl 1():18-25. PubMed ID: 3519380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist.
    Darius H; Thomsen T; Schrör K
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):144-52. PubMed ID: 2441164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.